Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include MicroRNA in disease regulation, Drug-Induced Hepatotoxicity and Protection, Circular RNAs in diseases, and Cancer-related molecular mechanisms research.
Lactate Metabolic Reprogramming Mediated by CircRNA-LDHA Complex Facilitates Innate Immune Evasion of Liver Cancer.
The glucose sensor NSUN2-m<sup>5</sup>C modification regulates tumor-immune glucose metabolism reprogramming to drive hepatocellular carcinoma evolution.
WITHDRAWN: Natural Killer Cell-Mediated Immunosurveillance Drives Liver Cancer Evolution Through Cancer Stemness Enhancement and Lipid Metabolism Reprogramming
WITHDRAWN: Natural Killer Cell-Mediated Immunosurveillance Drives Liver Cancer Evolution Through Cancer Stemness Enhancement and Lipid Metabolism Reprogramming
A Mammalian Conserved Circular RNA CircLARP1B Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism.
Potential of lncRNAs to regulate cuproptosis in hepatocellular carcinoma: Establishment and validation of a novel risk model.
HBV PreC interacts with SUV39H1 to induce viral replication by blocking the proteasomal degradation of viral polymerase.
Cytoskeleton remodeling mediated by circRNA-YBX1 phase separation suppresses the metastasis of liver cancer.
Exploring the boost of steaming with wine on Ligustri Lucidi Fructus in treating postmenopausal osteoporosis based on superior “multi-component structure” and iron/bone metabolism coregulation
The potential of mecciRNA in hepatic stellate cell to regulate progression of nonalcoholic hepatitis.
Circular RNAs: characteristics, biogenesis, mechanisms and functions in liver cancer.
An immunogenomic signature for molecular classification in hepatocellular carcinoma
A tumor-suppressive circular RNA mediates uncanonical integrin degradation by the proteasome in liver cancer.
Long non-coding RNA-based signature for predicting prognosis of hepatocellular carcinoma
Androgen receptor affects the response to immune checkpoint therapy by suppressing PD-L1 in hepatocellular carcinoma.
The role of natural killer cells in hepatocellular carcinoma development and treatment: A narrative review.
Inhibition of cytokine response to <scp>TLR</scp> stimulation and alleviation of collagen‐induced arthritis in mice by <i>Schistosoma japonicum</i> peptide <scp>SJMHE</scp>1
Increasing Prevalence of Type 2 Diabetes in Chinese Adults in Shanghai
Chemokine/chemokine receptor interactions contribute to the accumulation of Th17 cells in patients with esophageal squamous cell carcinoma